Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Licensing deals
Biotech
Kyowa Kirin fronts $330M to share rights to Kura's leukemia drug
Kyowa is pledging up to $1.1 billion in milestones to split the U.S. profits of Kura's oral leukemia treatment as well as to secure global rights.
James Waldron
Nov 21, 2024 9:35am
Novartis taps Ratio for $745M radiopharmaceutical pact
Nov 18, 2024 8:00am
Biotechs behind J&J-bought Yellow Jersey partner on IBD drug
Nov 15, 2024 8:30am
Merck pays $588M for bispecific to defend Keytruda’s kingdom
Nov 14, 2024 7:45am
Novartis pays Schrödinger $150M to form drug discovery pact
Nov 12, 2024 8:55am
GSK pays Flagship biotech $80M for preclinical neuro pact
Nov 12, 2024 6:30am
